Aligos Therapeutics, Inc. (ALGS) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ALGS Hot Sheet
Join SI Premium – FREE
Aligos Therapeutics, Inc. (NASDAQ: ALGS) reported Q2 EPS of ($0.43), $0.07 better than the analyst estimate of ($0.50).
For earnings history and earnings-related data on Aligos Therapeutics, Inc. (ALGS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Brinker International (EAT) Misses Q4 EPS by 2c ; Offers Guidance
- Riskified Ltd. (RSKD) Reports In-Line Q2 EPS ; Offers Guidance
- New York City REIT Inc. (NYC) Reports Q2 Loss of $3.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
